Search company, investor...
Search
Repertoire Immune Medicines company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

repertoire.com

Founded Year

2020

Stage

Series B | Alive

Total Raised

$189M

Last Raised

$189M | 1 yr ago

About Repertoire Immune Medicines

Repertoire Immune Medicines is the result of the merger between Cogen Immune Medicines and Torque Therapeutics. The firm aims to harnesses the human immune system’s intrinsic ability to cure disease by decoding relevant Antigen-TCR codes and deploying them as breakthrough immune medicines in immuno-oncology, autoimmune disorders, and infectious diseases.

Repertoire Immune Medicines Headquarters Location

One Kendall Square 1400W Suite 5

Cambridge, Massachusetts, 02139,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Repertoire Immune Medicines

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Repertoire Immune Medicines is included in 4 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

D

Diabetes

1,750 items

Repertoire Immune Medicines Patents

Repertoire Immune Medicines has filed 3 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biochemistry methods
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/9/2021

Immune system, Immunology, Clusters of differentiation, Pneumonia, Respiratory therapy

Application

Application Date

8/9/2021

Grant Date

Title

Related Topics

Immune system, Immunology, Clusters of differentiation, Pneumonia, Respiratory therapy

Status

Application

Latest Repertoire Immune Medicines News

Preclinical Research Published in Science Advances Demonstrates Repertoire Immune Medicines' Cell-Tethering Technology Delivers Potent Interleukin-12 Directly to Solid Tumors Potentially Improving Effectiveness of Cellular Immunotherapies – Business Wire

Apr 27, 2022

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines announced today that Science Advances published preclinical research demonstrating the company’s cell-tethering technology can deliver the potent cytokine interleukin-12 (IL-12) to solid tumors without eliciting the severe systemic toxicities typically associated with the use of this cytokine. The research, conducted in mouse models, found that the use of cell-tethered IL-12 […] The post Preclinical Research Published in Science Advances Demonstrates Repertoire Immune Medicines' Cell-Tethering Technology Delivers Potent Interleukin-12 Directly to Solid Tumors Potentially Improving Effectiveness of Cellular Immunotherapies – Business Wire appeared first on Business Telegraph.

Repertoire Immune Medicines Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Repertoire Immune Medicines Rank

  • When was Repertoire Immune Medicines founded?

    Repertoire Immune Medicines was founded in 2020.

  • Where is Repertoire Immune Medicines's headquarters?

    Repertoire Immune Medicines's headquarters is located at One Kendall Square 1400W, Cambridge.

  • What is Repertoire Immune Medicines's latest funding round?

    Repertoire Immune Medicines's latest funding round is Series B.

  • How much did Repertoire Immune Medicines raise?

    Repertoire Immune Medicines raised a total of $189M.

  • Who are the investors of Repertoire Immune Medicines?

    Investors of Repertoire Immune Medicines include Alaska Permanent Fund, Flagship Pioneering, Invus Group, SoftBank Group, Public Sector Pension Investment Board and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.